Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis

Tofacitinib is an oral Janus kinase inhibitor. Although it contributes to the induction and maintenance of clinical remission of patients with moderate-to-severe ulcerative colitis, various malignancies have been reported after the use of this small molecule. We report a rare case of biopsy-proven K...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetwittayakhlang, Panu, Golovics, Petra A., Afif, Waqqas, Bessissow, Talat, Lakatos, Peter L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613348/
https://www.ncbi.nlm.nih.gov/pubmed/34840995
http://dx.doi.org/10.14309/crj.0000000000000678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613348/
https://www.ncbi.nlm.nih.gov/pubmed/34840995
http://dx.doi.org/10.14309/crj.0000000000000678

Ejemplares similares